Investing.com - Medtronic (NYSE: MDT ) reported third quarter EPS of $1.39, $0.03 better than the analyst estimate of $1.36. Revenue for the quarter came in at $8.29B versus the consensus estimate of $8.33B.

Guidance

Medtronic sees FY 2025 EPS of $5.44-$5.50 versus the analyst consensus of $5.45.

Medtronic's stock price closed at $92.81. It is up 9.52% in the last 3 months and up 9.94% in the last 12 months.

Medtronic saw 1 positive EPS revisions and 23 negative EPS revisions in the last 90 days. See Medtronic's stock price’s past reactions to earnings here .

According to InvestingPro , Medtronic's Financial Health score is " good performance ".

Check out Medtronic's recent earnings performance , and Medtronic's financials here .

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar